News — SEATTLE – Sept. 16, 2024 –To highlight and celebrate the many contributions of Hispanic and Latinx scientists, has launched an . Led by , PhD, MM, the public, online resource of more than 380 Hispanic and Latinx scientists serves as a space to build community and create mentorship opportunities.
The atlas, which will be updated yearly with new nominees, highlights scientists with wide-ranging scientific expertise, from mathematical biology and ecology to neurology, and who research disease areas such as cancer, malaria, cardiovascular disease, HIV/AIDS and Alzheimer’s disease.
“For rising generations of scientists, this atlas is about providing a forum of role models,” said Termini, an assistant professor in the Translational Sciences and Therapeutics and Human Biology Divisions at Fred Hutch. “It has the potential to reinforce the identity of Hispanic and Latinx scientists and show that it is possible to achieve careers in all these different fields.”
showed that from 2011 to 2021, the share of Hispanic and Latinx individuals working in STEM fields increased from 11% to 15%. However, despite the overall rise in Hispanic and Latinx representation in STEM fields, in 2022 only . The atlas is a step toward advancing equitable representation of Hispanic and Latinx individuals among university faculty positions and the broader scientific community.
“I am Hispanic, so this issue is near and dear to me. It’s important to give back to my community by showcasing the amazing people that are part of our community, and to bring awareness that we are here,” pointed out Termini. “The atlas moves the onus of responsibility to the organizers of seminars or search committees who can use this resource to find those scientists that they claim are not there.”
In addition to leading the atlas project, Termini co-directs the , a program at Fred Hutch that supports early-career scientists from disadvantaged backgrounds. Her studies how specific kinds of sugars support normal blood and blood cancer cells.
Additional Fred Hutch scientists recognized in the atlas include:
- , PhD, a cancer cell biologist focusing on metabolic pathways that can lead to recurrence of dormant breast cancer cells,
- , PhD, a microbiologist working to understand how viruses hijack the DNA packaging of the cells they infect,
- , PhD, a genomics and virology scientist who combines computational and lab-based methods to explore how changes in antiviral strategies are driven by the constant struggle with past and current viral infections,
- , MD, PhD, an epidemiologist who specializes in identifying breast cancer risk factors and serves as Vice President for Faculty Affairs and Diversity at Fred Hutch and Associate Director, Diversity, Equity and Inclusion at the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and holds the Helen G. Edson Endowed Chair for Breast Cancer Research.
Termini collaborated with scientific peers JP Flores, Doris Cruz Alonso, Carolina Gomez Casas and Crystal Dezha-Bolteada to develop the atlas and verify each scientist listed. The researchers were motivated to expand on a list of that Termini created and published in the journal Cell in 2020. After experiencing significant interest in the initial list, the scientists created a permanent resource that could updated regularly.
To nominate yourself or a peer scientist to be added to the atlas, please complete the online nominating forms for or .
# # #
Media Contact:
Claire Hudson
[email protected]
206-667-2210
Fred Hutch Cancer Center
Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program.
RSS